Logo image of IQST

IQSTEL INC (IQST) Stock Fundamental Analysis

NASDAQ:IQST - Nasdaq - US46265G1076 - Common Stock - Currency: USD

12.602  +1.06 (+9.2%)

Fundamental Rating

1

Taking everything into account, IQST scores 1 out of 10 in our fundamental rating. IQST was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of IQST have multiple concerns. IQST has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year IQST has reported negative net income.
In the past year IQST has reported a negative cash flow from operations.
In the past 5 years IQST always reported negative net income.
In the past 5 years IQST always reported negative operating cash flow.
IQST Yearly Net Income VS EBIT VS OCF VS FCFIQST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2M -4M -6M

1.2 Ratios

Industry RankSector Rank
ROA -8.38%
ROE -91.71%
ROIC N/A
ROA(3y)-21.03%
ROA(5y)-43.18%
ROE(3y)-66.26%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IQST Yearly ROA, ROE, ROICIQST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

1.3 Margins

IQST's Gross Margin has declined in the last couple of years.
IQST does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 2.9%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.29%
GM growth 5Y-7.56%
IQST Yearly Profit, Operating, Gross MarginsIQST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

More info and screens

1

2. Health

2.1 Basic Checks

IQST does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, IQST has more shares outstanding
IQST has more shares outstanding than it did 5 years ago.
The debt/assets ratio for IQST is higher compared to a year ago.
IQST Yearly Shares OutstandingIQST Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
IQST Yearly Total Debt VS Total AssetsIQST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

IQST has an Altman-Z score of 3.25. This indicates that IQST is financially healthy and has little risk of bankruptcy at the moment.
IQST has a Debt/Equity ratio of 0.68. This is a neutral value indicating IQST is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF N/A
Altman-Z 3.25
ROIC/WACCN/A
WACC10.87%
IQST Yearly LT Debt VS Equity VS FCFIQST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M 8M

2.3 Liquidity

A Current Ratio of 0.99 indicates that IQST may have some problems paying its short term obligations.
IQST has a Quick Ratio of 0.99. This is a bad value and indicates that IQST is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.99
IQST Yearly Current Assets VS Current LiabilitesIQST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

3

3. Growth

3.1 Past

IQST shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -291.78%.
IQST shows a strong growth in Revenue. In the last year, the Revenue has grown by 95.96%.
IQST shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 73.47% yearly.
EPS 1Y (TTM)-291.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2300%
Revenue 1Y (TTM)95.96%
Revenue growth 3Y63.58%
Revenue growth 5Y73.47%
Sales Q2Q%109.24%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IQST Yearly Revenue VS EstimatesIQST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

IQST reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IQST Price Earnings VS Forward Price EarningsIQST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IQST Per share dataIQST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for IQST!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IQSTEL INC

NASDAQ:IQST (6/5/2025, 10:45:39 AM)

12.602

+1.06 (+9.2%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)05-13 2025-05-13
Earnings (Next)08-12 2025-08-12
Inst Owners0.01%
Inst Owner ChangeN/A
Ins Owners1.99%
Ins Owner Change0%
Market Cap36.55M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio0.24
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.13
P/FCF N/A
P/OCF N/A
P/B 5.06
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.86
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.06
FCFYN/A
OCF(TTM)-1.01
OCFYN/A
SpS97.65
BVpS2.49
TBVpS-2.4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.38%
ROE -91.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 2.9%
FCFM N/A
ROA(3y)-21.03%
ROA(5y)-43.18%
ROE(3y)-66.26%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.29%
GM growth 5Y-7.56%
F-Score1
Asset Turnover3.58
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 30.35%
Cap/Sales 0.05%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.99
Quick Ratio 0.99
Altman-Z 3.25
F-Score1
WACC10.87%
ROIC/WACCN/A
Cap/Depr(3y)97.68%
Cap/Depr(5y)135.43%
Cap/Sales(3y)0.11%
Cap/Sales(5y)0.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-291.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2300%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)95.96%
Revenue growth 3Y63.58%
Revenue growth 5Y73.47%
Sales Q2Q%109.24%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-844.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-80.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-97.49%
OCF growth 3YN/A
OCF growth 5YN/A